Evox Therapeutics Limited news

Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announced that the Company has been granted a new European patent, EP3706796, to add to its growing patent portfolio. This patent covers exosomes loaded with nucleic acids or ribonuclear protein complexes.

The granted claims add to Evox’s patent estate, providing further protection for exosomes carrying therapeutic nucleic acid cargos such as mRNA, shRNA, miRNA,